SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Allianz SE (ALIZF) trades at a trailing P/E of 15.3, forward P/E of 12.3. Trailing earnings yield is 6.55%, forward earnings yield 8.11%. PEG 1.12.
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (15.3); earnings yield beats bond yields (6.55%).
- Forward P/E 12.3 (down from trailing 15.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.12 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 6.55% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 8.11% as earnings recover.
Overall SharesGrow Score: 78/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ALIZF
Valuation Multiples
P/E (TTM)15.3
Forward P/E12.3
PEG Ratio1.12
Forward PEG0.52
P/B Ratio0.00
P/S Ratio1.19
EV/EBITDA0.0
Per Share Data
EPS (TTM)$28.60
Forward EPS (Est.)$35.38
Book Value / Share$0.00
Revenue / Share$365.91
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.55%
Forward Earnings Yield8.11%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$15.06 |
$107.66B |
$6.96B |
6.5% |
| 2017 |
$15.23 |
$107.43B |
$6.8B |
6.3% |
| 2018 |
$17.35 |
$102.95B |
$7.46B |
7.2% |
| 2019 |
$18.90 |
$113B |
$7.91B |
7% |
| 2020 |
$16.32 |
$112.24B |
$6.81B |
6.1% |
| 2021 |
$15.83 |
$118.91B |
$6.61B |
5.6% |
| 2022 |
$15.86 |
$61.94B |
$6.42B |
10.4% |
| 2023 |
$21.19 |
$103.01B |
$8.54B |
8.3% |
| 2024 |
$25.18 |
$139.84B |
$9.93B |
7.1% |
| 2025 |
$28.60 |
$137.81B |
$10.77B |
7.8% |
